Dermatologic Disorders — Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics
Citation(s)
Ernst E, Pittler MH, Stevinson C Complementary/alternative medicine in dermatology: evidence-assessed efficacy of two diseases and two treatments. Am J Clin Dermatol. 2002;3(5):341-8. Review.
Ernst E The usage of complementary therapies by dermatological patients: a systematic review. Br J Dermatol. 2000 May;142(5):857-61. Review.
Fuhrmann T, Smith N, Tausk F Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey. J Am Acad Dermatol. 2010 Dec;63(6):1000-5. doi: 10.1016/j.jaad.2009.12.009. Epub 2010 Oct 8.
Parkman CA CAM therapies and nursing competency. J Nurses Staff Dev. 2002 Mar-Apr;18(2):61-5; quiz 66-7.
Smith N, Shin DB, Brauer JA, Mao J, Gelfand JM Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol. 2009 Mar;60(3):419-25. doi: 10.1016/j.jaad.2008.11.905. Epub 2009 Jan 20.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
